De terugbetaling van innovatieve geneesmiddelen

This procedure concerns the reimbursement of innovative medicines in Belgium. It addresses how new and advanced medical treatments will be funded and made accessible to patients. The focus is on ensuring that patients can benefit from the latest medical advancements while managing healthcare costs effectively for the Belgian healthcare system.